Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
2
|
| pubmed:dateCreated |
1985-9-30
|
| pubmed:abstractText |
The antiviral efficacy of several compounds was demonstrated against Coxsackie viruses type A9, B1, B3, B4 and B5, echoviruses type 6, 11, 30, and 33, attenuated polioviruses and rhinovirus 1B. In one-step growth cycle experiments virus multiplication was clearly inhibited by application of the compounds immediately after virus adsorption.
|
| pubmed:language |
ger
|
| pubmed:journal | |
| pubmed:citationSubset |
IM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:issn |
0377-8177
|
| pubmed:author | |
| pubmed:issnType |
Print
|
| pubmed:volume |
36
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
111-7
|
| pubmed:dateRevised |
2006-11-15
|
| pubmed:meshHeading |
pubmed-meshheading:2994289-Antiviral Agents,
pubmed-meshheading:2994289-Drug Evaluation, Preclinical,
pubmed-meshheading:2994289-Enterovirus,
pubmed-meshheading:2994289-Enterovirus B, Human,
pubmed-meshheading:2994289-Microbial Sensitivity Tests,
pubmed-meshheading:2994289-Poliovirus,
pubmed-meshheading:2994289-Rhinovirus
|
| pubmed:articleTitle |
[In vitro effectiveness of new antiviral substances. 2. studies with enteroviruses and rhinovirus lB].
|
| pubmed:publicationType |
Journal Article,
English Abstract
|